Amcad Biomed CorporationTPEX: 4188

Announcing termination of private equity offering which was approved by 2021 Annual Shareholders' Meeting.

· Issued by AmCad BioMed Corporation
Close
Today's Information

Provided by: AmCad BioMed Corporation
SEQ_NO 6 Date of announcement 2022/02/18 Time of announcement 16:30:25
Subject
 Announcing termination of private equity offering
which was approved by 2021 Annual Shareholders' Meeting.
Date of events 2022/02/18 To which item it meets paragraph 16
Statement
1.Date of the board of directors resolution for the change:2022/02/18
2.Effective registration date of the original plan:2021/05/21
3.Resolution date of additional issuance:N/A
4.Major change Reason for the change:
 (1)The Company's 2021 Annual Shareholders' Meeting has authorized
    Board of Directors to issue Private Placement Common Shares.
 (2)According to Article 43-6, Securities and Exchange Law, the private
    placement may be carried out by installments within one year of the
    date of the resolution of the shareholders meeting. In consideration of
    the capital market circumstances, the Company will not continue with
    the above private placement.
5.Content of each and every successive previously changed
plan for raising of funds before and after change:N/A
6.Projected timetable for execution:N/A
7.Projected completion date:N/A
8.Projected possible benefits:N/A
9.Difference from original projected benefits:N/A
10.Effect of the current change on shareholder equity:N/A
11.Abstract of the original lead underwriter's appraisal opinion:N/A
12.Any other matters that need to be specified:None

Earlier from Amcad Biomed

All Amcad Biomed news releases